Skip to main content

NHGRI Using Biofortis' Labmatrix for ClinSeq Studies

NEW YORK (GenomeWeb News) — The National Human Genome Research Institute is using Biofortis’ Labmatrix data-management software in its ClinSeq sequencing program, which intends to sequence the genomes of 1,000 human subjects and to continue research with these subjects over time in the clinical setting, Biofortis said last week.
The NHGRI told GenomeWeb Daily News in May it will use 14 Applied Biosystems 3730 sequencers to screen 1,000 individuals with symptoms of coronary heart disease for between 200 and 400 genes linked to the condition.
Biofortis said the NHGRI is using Labmatrix to “manage and integrate patient, sample tracking, and genetic data.”
NHGRI has already been using Labmatrix as its central database in its intramural research programs, Biofortis CEO Ethel Rubin told GenomeWeb Daily News sister publication BioInform last week.
Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.